Cargando…
UVRAG Deficiency Exacerbates Doxorubicin-Induced Cardiotoxicity
Doxorubicin (DOX) is an effective chemotherapeutic drug in the treatment of various types of cancers. However, its clinical application has been largely limited by potential development of cardiotoxicity. Previously we have shown that ultra-violet radiation resistance-associated gene (UVRAG), an aut...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320807/ https://www.ncbi.nlm.nih.gov/pubmed/28225086 http://dx.doi.org/10.1038/srep43251 |